Littisha LAWRANCE

Mrs. Littisha LAWRANCE

Laboratoire d’Imagerie Biomédicale Multimodale Paris-Saclay. BIOMAPS, UMR 1281.Université Paris-Saclay, Inserm, CNRS, CEA, Villejuif, Île-de-France, France
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
YLYingping LI
Yingping LI
SASAMY AMMARI
SAMY AMMARI
LLLittisha LAWRANCE
Littisha LAWRANCE
AQArnaud Quillent
Arnaud Quillent
TATAREK Assi
TAREK Assi
ECEmilie Chouzenoux
Emilie Chouzenoux
Gliomas are among the most common types of central nervous system (CNS) tumors. A prompt diagnosis of the glioma subtype is crucial to estimate the prognosis and personalize the treatment strategy. The objective of this study was to develop a radiomics pipeline based on the clinical Magnetic Resonance Imaging (MRI) scans to noninvasively predict the glioma subtype, as defined based on the tumor grade, isocitrate dehydrogenase (IDH) mutation status, and 1p/19q codeletion status. A total of 212 patients from the public retrospective The Cancer Genome Atlas Low Grade Glioma (TCGA-LGG) and The Cancer Genome Atlas Glioblastoma Multiforme (TCGA-GBM) datasets were used for the experiments and analyses. Different settings in the radiomics pipeline were investigated to improve the classification, including the Z-score normalization, the feature extraction strategy, the image filter applied to the MRI images, the introduction of clinical information, ComBat harmonization, the classifier chain strategy, etc. Based on numerous experiments, we finally reached an optimal pipeline for classifying the glioma tumors. We then tested this final radiomics pipeline on the hold-out test data with 51 randomly sampled random seeds for reliable and robust conclusions. The results showed that, after tuning the radiomics pipeline, the mean AUC improved from 0.8935 (±0.0351) to 0.9319 (±0.0386), from 0.8676 (±0.0421) to 0.9283 (±0.0333), and from 0.6473 (±0.1074) to 0.8196 (±0.0702) in the test data for predicting the tumor grade, IDH mutation, and 1p/19q codeletion status, respectively. The mean accuracy for predicting the five glioma subtypes also improved from 0.5772 (±0.0816) to 0.6716 (±0.0655). Finally, we analyzed the characteristics of the radiomic features that best distinguished the glioma grade, the IDH mutation, and the 1p/19q codeletion status, respectively. Apart from the promising prediction of the glioma subtype, this study also provides a better understanding of the radiomics model development and interpretability. The results in this paper are replicable with our python codes publicly available in github.

16 August 2022 in European Journal of Cancer
Verified
Journal Article
Open access
KSKathryn Schutte
Kathryn Schutte
FBFabien Brulport
Fabien Brulport
SHSana Harguem-Zayani
Sana Harguem-Zayani
JSJean-Baptiste Schiratti
Jean-Baptiste Schiratti
RGRidouane Ghermi
Ridouane Ghermi
NLNathalie Lassau
Nathalie Lassau
The need for developing new biomarkers is increasing with the emergence of many targeted therapies. Artificial Intelligence (AI) algorithms have shown great promise in the medical imaging field to build predictive models. We developed a prognostic model for solid tumour patients using AI on multimodal data. Our retrospective study included examinations of patients with seven different cancer types performed between 2003 and 2017 in 17 different hospitals. Radiologists annotated all metastases on baseline computed tomography (CT) and ultrasound (US) images. Imaging features were extracted using AI models and used along with the patients' and treatments' metadata. A Cox regression was fitted to predict prognosis. Performance was assessed on a left-out test set with 1000 bootstraps. The model was built on 436 patients and tested on 196 patients (mean age 59, IQR: 51-6, 411 men out of 616 patients). On the whole, 1147 US images were annotated with lesions delineation, and 632 thorax-abdomen-pelvis CTs (total of 301,975 slices) were fully annotated with a total of 9516 lesions. The developed model reaches an average concordance index of 0.71 (0.67-0.76, 95% CI). Using the median predicted risk as a threshold value, the model is able to significantly (log-rank test P value < 0.001) isolate high-risk patients from low-risk patients (respective median OS of 11 and 31 months) with a hazard ratio of 3.5 (2.4-5.2, 95% CI). AI was able to extract prognostic features from imaging data, and along with clinical data, allows an accurate stratification of patients' prognoses.

5 October 2022 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
SMSébastien Mulé
Sébastien Mulé
LLLittisha LAWRANCE
Littisha LAWRANCE
YBYounes Belkouchi
Younes Belkouchi
VVValérie Vilgrain
Valérie Vilgrain
MLMaité Lewin
Maité Lewin
NLNathalie Lassau
Nathalie Lassau

1 November 2024 in Radiology
Verified
Journal Article
Closed access
LDLama Dawi
Lama Dawi
YBYounes Belkouchi
Younes Belkouchi
LLLittisha LAWRANCE
Littisha LAWRANCE
OGOthilie Gautier
Othilie Gautier
SASAMY AMMARI
SAMY AMMARI
NLNathalie Lassau
Nathalie Lassau
Tumor fraction at liquid biopsy was weakly correlated with the total tumor volume at contrast-enhanced CT and did not accurately reflect the tumor burden at contrast-enhanced CT.

1 November 2021 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
NLNathalie Lassau
Nathalie Lassau
IBImad Bousaid
Imad Bousaid
ECEmilie Chouzenoux
Emilie Chouzenoux
AVAntoine Verdon
Antoine Verdon
CBCorinne Balleyguier
Corinne Balleyguier
JMJean-François Meder
Jean-François Meder

5 January 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
PDPierre Decazes
Pierre Decazes
SASAMY AMMARI
SAMY AMMARI
APAntoine de Prévia
Antoine de Prévia
LMLéo Antoine MOTTAY
Léo Antoine MOTTAY
LLLittisha LAWRANCE
Littisha LAWRANCE
NLNathalie Lassau
Nathalie Lassau
Background: Body composition could help to better define the prognosis of cancers treated with anti-angiogenics. The aim of this study is to evaluate the prognostic value of 3D and 2D anthropometric parameters in patients given anti-angiogenic treatments. Methods: 526 patients with different types of cancers were retrospectively included. The software Anthropometer3DNet was used to measure automatically fat body mass (FBM3D), muscle body mass (MBM3D), visceral fat mass (VFM3D) and subcutaneous fat mass (SFM3D) in 3D computed tomography. For comparison, equivalent two-dimensional measurements at the L3 level were also measured. The area under the curve (AUC) of the receiver operator characteristics (ROC) was used to determine the parameters’ predictive power and optimal cut-offs. A univariate analysis was performed using Kaplan–Meier on the overall survival (OS). Results: In ROC analysis, all 3D parameters appeared statistically significant: VFM3D (AUC = 0.554, p = 0.02, cutoff = 0.72 kg/m2), SFM3D (AUC = 0.544, p = 0.047, cutoff = 3.05 kg/m2), FBM3D (AUC = 0.550, p = 0.03, cutoff = 4.32 kg/m2) and MBM3D (AUC = 0.565, p = 0.007, cutoff = 5.47 kg/m2), but only one 2D parameter (visceral fat area VFA2D AUC = 0.548, p = 0.034). In log-rank tests, low VFM3D (p = 0.014), low SFM3D (p < 0.0001), low FBM3D (p = 0.00019) and low VFA2D (p = 0.0063) were found as a significant risk factor. Conclusion: automatic and 3D body composition on pre-therapeutic CT is feasible and can improve prognostication in patients treated with anti-angiogenic drugs. Moreover, the 3D measurements appear to be more effective than their 2D counterparts.